BLCO Stock Analysis: Buy, Sell, or Hold?

BLCO - Bausch + Lomb Corporation

OPHTHALMIC GOODS
$16.73
0.03 (0.18%) ▲
5d: -0.83%
30d: -2.05%
90d: +10.5%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Feb 18, 2026 15d

Get Alerted When BLCO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: BLCO shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$33.28
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$20.67
19.0% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.3x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BLCO is currently trading at $16.73, which is considered oversold relative to its 30-day fair value range of $16.83 to $17.34. The stock's valuation (Forward PE: 20.8) is in line with its historical norms (21.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.8% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, BLCO is in a strong uptrend. The price is currently testing key support at $16.56. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $16.83 - $17.34
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.6%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($17.54)

Fair Price Analysis

30-Day Fair Range $16.83 - $17.34
Current vs Fair Value OVERSOLD
Expected Move (7 Days) ±$1.34 (8.0%)

Support & Resistance Levels

Support Level $16.56
Resistance Level $17.54
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 20.81
Wall Street Target $17.54 (+5.0%)
Revenue Growth (YoY) 7.1%
Earnings Growth (YoY) -88.6%
Profit Margin -6.1%
Valuation Discount vs History -0.8% cheaper
PE vs Historical 20.8 vs 21.3 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -0.8% (market-implied from PE analysis)
1-Year Target $16.57 (-1%)
2-Year Target $16.43 (-2%)
3-Year Target $16.30 (-2%)
3-Yr Target (if PE normalizes) (PE: 21→21) $16.68 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 51.2%) $60.39 (+262%)
Base: (SPY PE: 20.8, Growth: 51.2%) $56.36 (+238%)
Bear: (PE: 17.7, Growth: 51.2%) $47.91 (+187%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.8 to 21.3
Stabilization Target: $17.09 (+2.3%)
PE Expansion Potential: +2.3%
Last updated: February 02, 2026 12:52 PM ET
Data refreshes hourly during market hours. Next update: 1:52 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$612 57 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$92 59 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$191 56 HOLD
RMD
ResMed Inc
BUY
19 analysts
$297 57 HOLD
COO
The Cooper Companies, Inc
BUY
19 analysts
$91 62 BUY

More Analysis for BLCO

BLCO Technical Chart BLCO Price Prediction BLCO Earnings Date BLCO Investment Advisor BLCO Fair Price Analyzer BLCO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals